Methionine synthase A2756G polymorphism and cancer risk: A meta-analysis

European Journal of Human Genetics

Volumn 18, Issue 3, 2010, Pages 370-378

  Yu, Ke ^a   Zhang, Jing ^a   Zhang, Jiyuan ^a   Dou, Chao ^a   Gu, Shaohua ^a   Xie, Yi ^a   Mao, Yumin ^a   Ji, Chaoneng ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Cancer; Meta analysis; MTR; Polymorphism

Indexed keywords

ADENINE; GUANINE; METHIONINE SYNTHASE;

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; ASIAN; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; ETHNICITY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC MODEL; GENOTYPE; HETEROZYGOTE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; POPULATION GENETICS; PRIORITY JOURNAL; RISK REDUCTION;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; AMINO ACID SUBSTITUTION; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPE; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS;

EID: 77149128957     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2009.131     Document Type: Article

References (59)

1. Pufulete M, Al-Ghnaniem R, Leather AJ et al: Folate status, genomic DNA hypo-methylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology 2003; 124: 1240-1248.
2. Ma J, Stampfer MJ, Christensen B et al: A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1999; 8: 825-829.
3. Matsuo K, Suzuki R, Hamajima N et al: Association between polymorphisms of folate-and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood 2001; 97: 3205-3209.
4. Goode EL, Potter JD, Bigler J et al: Methionine synthase D919G polymorphism, folate metabolism, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2004; 13: 157-162.
5. Paz MF, Avila S, Fraga MF et al: Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res 2002; 62: 4519-4524.
6. Woolf B: On estimating the relation between blood group and disease. Ann Hum Genet 1955; 19: 251-253.
7. Lau J, Ioannidis JP, Schmid CH: Quantitative synthesis in systematic reviews. Ann Intern Med 1997; 127: 820-826.
8. Higgins JP, Thompson SG, Deeks JJ et al: Measuring inconsistency in meta-analyses. Br Med J 2003; 327: 557-560.
9. Petitti DB: Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis. Oxford University Press: New York, 1994.
10. Thompson SG, Sharp SJ: Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 1999; 18: 2693-2708.
11. Egger M, Davey Smith G, Schneider M et al: Bias in meta-analysis detected by a simple, graphical test. Bmj 1997; 315: 629-634.
12. Suzuki T, Matsuo K, Hasegawa Y et al: One-carbon metabolism-related gene polymorphisms and risk of head and neck squamous cell carcinoma: case-control study. Cancer Sci 2007; 98: 1439-1446. (Pubitemid 47241768)
13. Matsuo K, Ito H, Wakai K et al: One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan. Carcinogenesis 2005; 26: 2164-2171.
14. Hazra A, Wu K, Kraft P et al: Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses¢ Health Study. Carcinogenesis 2007; 28: 1510-1519.
15. Gast A, Bermejo JL, Flohr T et al: Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case-control study. Leukemia 2007; 21: 320-325.
16. Petra BG, Janez J, Vita D: Gene-gene interactions in the folate metabolic pathway influence the risk for acute lymphoblastic leukemia in children. Leuk Lymphoma 2007; 48: 786-792.
17. Yang CX, Matsuo K, Ito H et al: Gene-environment interactions between alcohol drinking and the MTHFR C677T polymorphism impact on esophageal cancer risk: results of a case-control study in Japan. Carcinogenesis 2005; 26: 1285-1290.
18. Zhang FF, Terry MB, Hou L et al: Genetic polymorphisms in folate metabolism and the risk of stomach cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 115-121.
19. Shi Q, Zhang Z, Li G et al: Polymorphisms of methionine synthase and methionine synthase reductase and risk of lung cancer: a case-control analysis. Pharmacogenet Genomics 2005; 15: 547-555. (Pubitemid 41044240)
20. Suzuki T, Matsuo K, Hiraki A et al: Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study. Carcinogenesis 2007; 28: 1718-1725.
21. Kim HN, Kim YK, Lee IK et al: Polymorphisms involved in the folate metabolizing pathway and risk of multiple myeloma. Am J Hematol 2007; 82: 798-801.
22. Lima CS, Ortega MM, Ozelo MC et al: Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk. Leuk Res 2008; 32: 401-405.
23. Semmler A, Simon M, Moskau S et al: The methionine synthase polymorphism c.2756A4G alters susceptibility to glioblastoma multiforme. Cancer Epidemiol Biomarkers Prev 2006; 15: 2314-2316.
24. Semmler A, Simon M, Moskau S et al: Polymorphisms of methionine metabolism and susceptibility to meningioma formation: laboratory investigation. J Neurosurg 2008; 108: 999-1004.
25. Kang S, Kim JW, Kang GH et al: Polymorphism in folate-and methionine-metaboliz-ing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer. Gynecol Oncol 2005; 96: 173-180.
26. Shekari M, Sobti RC, Kordi Tamandani DM et al: Impact of methylenetetrahydrofolate reductase (MTHFR) codon (677) and methionine synthase (MS) codon (2756) on risk of cervical carcinogenesis in North Indian population. Arch Gynecol Obstet 2008; 278: 517-524.
27. Ulrich CM, Curtin K, Potter JD et al: Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 2509-2516.
28. Zhang Z, Shi Q, Liu Z et al: Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Cancer Epidemiol Biomarkers Prev 2005; 14: 1188-1193. (Pubitemid 40656465)
29. Bethke L, Webb E, Murray A et al: Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev 2008; 17: 1195-1202.
30. Ott N, Geddert H, Sarbia M: Polymorphisms in methionine synthase (A2756G) and cystathionine beta-synthase (844ins68) and susceptibility to carcinomas of the upper gastrointestinal tract. J Cancer Res Clin Oncol 2008; 134: 405-410.
31. Hung RJ, Hashibe M, McKay J et al: Folate-related genes and the risk of tobacco-related cancers in Central Europe. Carcinogenesis 2007; 28: 1334-1340.
32. Gemmati D, Ongaro A, Scapoli GL et al: Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin¢s lymphoma in adults. Cancer Epidemiol Biomarkers Prev 2004; 13: 787-794.
33. Kimura F, Franke KH, Steinhoff C et al: Methyl group metabolism gene polymorphisms and susceptibility to prostatic carcinoma. Prostate 2000; 45: 225-231.
34. Lincz LF, Scorgie FE, Kerridge I et al: Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin¢s lymphoma or multiple myeloma. Br J Haematol 2003; 120: 1051-1054.
35. Lin J, Spitz MR, Wang Y et al: Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. Carcinogenesis 2004; 25: 1639-1647.
36. Le Marchand L, Donlon T, Hankin JH et al: B-vitamin intake, metabolic genes and colorectal cancer risk (United States). Cancer Causes Control 2002; 13: 239-248.
37. Marchal C, Redondo M, Reyes-Engel A et al: Association between polymorphisms of folate-metabolizing enzymes and risk of prostate cancer. Eur J Surg Oncol 2008; 34: 805-810.
38. Wang L, Lin DX, Lu XH et al: Study on the relations between genetic polymorphisms in methylenetetrahydrofolate reductase, methionine synthase and the risk of pancreatic cancer. Zhonghua Liu Xing Bing Xue Za Zhi 2006; 27: 50-54.
39. Moore LE, Hung R, Karami S et al: Folate metabolism genes, vegetable intake and renal cancer risk in central Europe. Int J Cancer 2008; 122: 1710-1715.
40. Sirachainan N, Wongruangsri S, Kajanachumpol S et al: Folate pathway genetic polymorphisms and susceptibility of central nervous system tumors in Thai children. Cancer Detect Prev 2008; 32: 72-78.
41. Linnebank M, Schmidt S, Kolsch H et al: The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma. Br J Cancer 2004; 90: 1969-1971.
42. Matsuo K, Hamajima N, Suzuki R et al: Methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms and reduced risk of malignant lymphoma. Am J Hematol 2004; 77: 351-357.
43. Lightfoot TJ, Skibola CF, Willett EV et al: Risk of non-Hodgkin's lymphoma associated with polymorphisms in folate-metabolizing genes. Cancer Epidemiol Biomarkers Prev 2005; 14: 2999-3003.
44. Niclot S, Pruvot Q, Besson C et al: Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphomas. Blood 2006; 108: 278-285.
45. Lee KM, Lan Q, Kricker A et al: One-carbon metabolism gene polymorphisms and risk of non-Hodgkin's lymphoma in Australia. Hum Genet 2007; 122: 525-533. (Pubitemid 350148964)
46. Lim U, Wang SS, Hartge P et al: Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. Blood 2007; 109: 3050-3059.
47. Kim HN, Lee IK, Kim YK et al: Association between folate-metabolizing pathway polymorphism and non-Hodgkin's lymphoma. Br J Haematol 2008; 140: 287-294.
48. Matsuo K, Hamajima N, Hirai T et al: Methionine synthase reductase gene A66G polymorphism is associated with risk of colorectal cancer. Asian Pac J Cancer Prev 2002; 3: 353-359.
49. Ulvik A, Vollset SE, Hansen S et al: Colorectal cancer and the methylenetetrahydro-folate reductase 677C-4 T and methionine synthase 2756A-4 G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort. Cancer Epidemiol Biomarkers Prev 2004; 13: 2175-2180.
50. Koushik A, Kraft P, Fuchs CS et al: Nonsynonymous polymorphisms in genes in the one-carbon metabolism pathway and associations with colorectal cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 2408-2417.
51. Theodoratou E, Farrington SM, Tenesa A et al: Dietary vitamin B6 intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 171-182.
52. Justenhoven C, Hamann U, Pierl CB et al: One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany. Cancer Epidemiol Biomarkers Prev 2005; 14: 3015-3018.
53. Shrubsole MJ, Gao YT, Cai Q et al: MTR and MTRR polymorphisms, dietary intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15: 586-588.
54. Yu CP, Wu MH, Chou YC et al.: Breast cancer risk associated with multigenotypic polymorphisms in folate-metabolizing genes: a nested case-control study in Taiwan. Anticancer Res 2007; 27: 1727-1732.
55. Kotsopoulos J, Zhang WW, Zhang S et al: Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer. Breast Cancer Res Treat 2008; 112: 585-593.
56. Suzuki T, Matsuo K, Hirose K et al: One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis 2008; 29: 356-362.
57. Kimura F, Florl AR, Steinhoff C et al: Polymorphic methyl group metabolism genes in patients with transitional cell carcinoma of the urinary bladder. Mutat Res 2001; 458: 49-54.
58. Ouerhani S, Oliveira E, Marrakchi R et al: Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population. Cancer Genet Cytogenet 2007; 176: 48-53.
59. Chen J, Giovannucci E, Hankinson SE et al: A prospective study of methylenetetrahy-drofolate reductase and methionine synthase gene polymorphisms, and risk of color-ectal adenoma. Carcinogenesis 1998; 19: 2129-2132.